Study Shows 80% Long-Term Survival Results of Low Dose CT Lung Cancer Screening

A 20-year study conducted by the global I-ELCAP team confirms that low dose CT lung cancer screening has an outstanding 80% long-term survival rate. In those 20 years, I-ELCAP has supported around 90,000 lung screening participants, almost 300 publications and numerous international study confirmations. The I-ELCAP lung screening protocol represents a major advance in the war on cancer. To read more, visit

Contact Accumetra at to learn how to deploy ScreeningPLUS, the commercially available version of the I-ELCAP lung cancer screening management system, at your institution.